French company DNA Script will contribute its enzymatic DNA synthesis technologies, while Quantoom of Belgium will bring its ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...
Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA ...
News Medical on MSN1d
Disrupting the RBM42 protein could throw a wrench in the gears of cancer's growthFor decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...
UCSF scientists discover how cancer cells hijack the protein factory of the cell to churn out MYC protein, the driver of 70% ...
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists think they ...
The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...
"If the endosomal escape process doesn't happen ... the end of LNPs' normally linear lipid tails dramatically improved mRNA delivery. This discovery prompted Marshall Padilla, a postdoctoral ...
Researchers developed a technique to gain a deeper understanding of ribosome function and their cooperative behaviors.
TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback